Xenon Pharmaceuticals (XENE)
(Delayed Data from NSDQ)
$41.01 USD
+0.64 (1.59%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $41.02 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 37% (93 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.12 | 1.35 | 9.99 |
Current Quarter Estimate | -0.72 | 7.43 | 61.00 |
Year Ago Quarter Estimate | -0.72 | 0.12 | 54.84 |
Next Quarter Estimate | -0.77 | 7.81 | 63.00 |
Next Year Estimate | -3.41 | 37.76 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -9.16 | 16.40 | 15.67 |
Next Year | -14.43 | 9.60 | 11.34 |
Last 5 Years | -277.70 | 0.70 | 8.10 |
Next 5 Years | 3.50 | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 3.43 | 2.03 |
Price/Cash Flow (MRFY) | NA | 16.15 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -22.37% |
Return on Equity (TTM) | -24.35% | -31.10% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.